Olfactory Dysfunction in Mental Illness
- PMID: 36696016
- PMCID: PMC9875195
- DOI: 10.1007/s11882-023-01068-z
Olfactory Dysfunction in Mental Illness
Abstract
Purpose of review: Olfactory dysfunction contributes to the psychopathology of mental illness. In this review, we describe the neurobiology of olfaction, and the most common olfactory alterations in several mental illnesses. We also highlight the role, hitherto underestimated, that the olfactory pathways play in the regulation of higher brain functions and its involvement in the pathophysiology of psychiatric disorders, as well as the effect of inflammation on neurogenesis as a possible mechanism involved in olfactory dysfunction in psychiatric conditions.
Recent findings: The olfactory deficits present in anxiety, depression, schizophrenia or bipolar disorder consist of specific alterations of different components of the sense of smell, mainly the identification of odours, as well as the qualifications of their hedonic valence (pleasant or unpleasant). Epidemiological findings have shown that both environmental factors, such as air pollutants, and inflammatory disease of the upper respiratory tract, can contribute to an increased risk of mental illness, at least in part, due to peripheral inflammatory mechanisms of the olfactory system. In this review, we describe the neurobiology of olfaction, and the most common olfactory function alterations in several psychiatric conditions and its role as a useful symptom for the differential diagnosis. We also highlight the effect of inflammation on neurogenesis as a possible mechanism involved in olfactory dysfunction in these psychiatric conditions.
Keywords: Anxiety; Bipolar disorder; Depression; Mental illness; Neurogenesis; Olfaction; Olfactory bulbs; Olfactory neuroepithelium; Schizophrenia.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
C. Marin declares that she has no conflict of interest. I. Alobid has received speaker and consultancy honoraria from Viatris, Roche, Sanofi, GSK, MSD, Menarini, Salvat and Novartis. M. Fuentes declares that she has no conflict of interest. M. López-Chacón declares that he has no conflict of interest. J. Mullol has received speaker and consultancy honoraria, and grants from Sanofi-Genzyme & Regeneron, Novartis, Viatris, Uriach Group, Mitsubishi-Tanabe, Menarini, UCB, AstraZeneca, GSK and MSD.
Figures
References
-
- Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, Borgmann-Winter KE, Kohler CG, Gur RE, Turetsky BI. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at risk for psychosis. Schizophr Bull. 2014;40:50–59. doi: 10.1093/schbul/sbt049. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
